Petra Heffeter

8.9k total citations · 2 hit papers
190 papers, 7.4k citations indexed

About

Petra Heffeter is a scholar working on Oncology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Petra Heffeter has authored 190 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Oncology, 81 papers in Molecular Biology and 41 papers in Organic Chemistry. Recurrent topics in Petra Heffeter's work include Metal complexes synthesis and properties (71 papers), Drug Transport and Resistance Mechanisms (29 papers) and Nanoparticle-Based Drug Delivery (20 papers). Petra Heffeter is often cited by papers focused on Metal complexes synthesis and properties (71 papers), Drug Transport and Resistance Mechanisms (29 papers) and Nanoparticle-Based Drug Delivery (20 papers). Petra Heffeter collaborates with scholars based in Austria, Hungary and Germany. Petra Heffeter's co-authors include Walter Berger, Bernhard K. Keppler, Christian R. Kowol, Michael A. Jakupec, Ute Jungwirth, Robert Trondl, Christian G. Hartinger, Christine Pirker, M. Micksche and M. Galanski and has published in prestigious journals such as Chemical Reviews, Journal of the American Chemical Society and Angewandte Chemie International Edition.

In The Last Decade

Petra Heffeter

184 papers receiving 7.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application

2014 583 citations Petra Heffeter, Christian R. Kowol et al. Chemical Science profile →
Anticancer Activity of Metal Complexes: Involvement of Redox Processes

2011 439 citations Ute Jungwirth, Christian R. Kowol et al. profile →

Peers

Countries citing papers authored by Petra Heffeter

Since Specialization

Citations

This map shows the geographic impact of Petra Heffeter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petra Heffeter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petra Heffeter more than expected).

Fields of papers citing papers by Petra Heffeter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petra Heffeter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petra Heffeter. The network helps show where Petra Heffeter may publish in the future.

Co-authorship network of co-authors of Petra Heffeter

This figure shows the co-authorship network connecting the top 25 collaborators of Petra Heffeter. A scholar is included among the top collaborators of Petra Heffeter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petra Heffeter. Petra Heffeter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Site-Selectively Functionalized Albumin with DFOMaleimide for ⁸⁹Zr-Radiolabeling Yields a Metabolically Stable PET Probe that Enables Late Time-Point Tumor Imaging in Mice 2025 ·Journal of Medicinal Chemistry* ·(unknown), Theresa Balber, Hemma Schueffl, (unknown), (unknown), (unknown), Marie Brandt, Thomas Wanek, Markus Mitterhauser, Christian R. Kowol, Thomas L. Mindt, Petra Heffeter	0
2	Hesperetin Protects from Palmitic-Acid-Induced Lipotoxicity through the Inhibition of Glutaminolysis, mTORC1 Signaling, and Limited Apoptosis 2025 ·Journal of Agricultural and Food Chemistry ·(unknown), Zhengnan Cai, (unknown), Martin Brenner, Christian Winter, Barbara Stiller, Petra Heffeter, Wolfram Weckwerth	0
3	Selectivity for TP53 signalling drives the mode of action of a highly potent N , O , O -tridentate naphthoquinone-based organo-ruthenium anticancer drug candidate 2025 ·Chemical Science ·(unknown), (unknown), (unknown), Dina Baier, Michaela Hejl, (unknown), (unknown), (unknown), Thomas Mohr, Anton A. Legin, Michael A. Jakupec, Andrea Bileck, Christopher Gerner, Gunda Koellensperger, Petra Heffeter, Walter Berger, Bernhard K. Keppler, Wolfgang Kandioller, Samuel M. Meier	0
4	Targeting PHGDH reverses the immunosuppressive phenotype of tumor-associated macrophages through α-ketoglutarate and mTORC1 signaling 2024 ·Cellular and Molecular Immunology ·Zhengnan Cai, Li Wan, Sonja Hager, Jayne Louise Wilson, (unknown), Elke H. Heiß, Thomas Weichhart, Petra Heffeter, Wolfram Weckwerth	38
5	Elevated PINK1/Parkin-Dependent Mitophagy and Boosted Mitochondrial Function Mediate Protection of HepG2 Cells from Excess Palmitic Acid by Hesperetin 2024 ·Journal of Agricultural and Food Chemistry ·(unknown), Zhengnan Cai, (unknown), (unknown), (unknown), Petra Heffeter, Elke H. Heiß, Wolfram Weckwerth	14
6	Sigma-2 Receptor Ligand Binding Modulates Association between TSPO and TMEM97 2023 ·International Journal of Molecular Sciences ·(unknown), Vittoria Infantino, Anna Santarsiero, (unknown), (unknown), (unknown), (unknown), Robert H. Mach, Nunzio Denora, Byung Chul Lee, Nicoletta Resta, Rosanna Bagnulo, Mauro Niso, Marialessandra Contino, (unknown), Petra Heffeter, Carmen Abate, Michael A. Cahill	8
7	Aberrant DNA Methylation, Expression, and Occurrence of Transcript Variants of the ABC Transporter ABCA7 in Breast Cancer 2023 ·Cells ·(unknown), (unknown), (unknown), (unknown), Lukas Schmidt, (unknown), (unknown), Martin Schreiber, (unknown), Christine Pirker, Georg Pfeiler, Stefan Hacker, Werner Haslik, Dietmar Pils, Andrea Bileck, Christopher Gerner, Samuel M. Meier, Petra Heffeter, Margit Cichna‐Markl	6
8	Detection of oxaliplatin- and cisplatin-DNA lesions requires different global genome repair mechanisms that affect their clinical efficacy 2023 ·NAR Cancer ·Jana Slyšková, (unknown), Israel Tojal da Silva, Rodrigo D. Drummond, Jiyeong Park, (unknown), (unknown), Cristina Ribeiro-Silva, Amandine Moretton, Petra Heffeter, Orlando D. Schärer, Wim Vermeulen, Hannes Lans, Joanna I. Loizou	4
9	Synthesis and Preclinical Evaluation of Radiolabeled [103Ru]BOLD-100 2023 ·Pharmaceutics ·(unknown), Marie Brandt, Theresa Balber, (unknown), Zeynep Talip, (unknown), Petra Heffeter, Wolfgang Kandioller, Nicholas P. van der Meulen, Markus Mitterhauser, Marcus Hacker, Bernhard K. Keppler, Thomas L. Mindt	4
10	Development of Fluorescent 4-[4-(3H-Spiro[isobenzofuran-1,4′-piperidin]-1′-yl)butyl]indolyl Derivatives as High-Affinity Probes to Enable the Study of σ Receptors via Fluorescence-Based Techniques 2023 ·Journal of Medicinal Chemistry ·(unknown), María Majellaro, (unknown), Rubén Prieto‐Díaz, Mauro Niso, Marialessandra Contino, Angela Stefanachi, Chiara Riganti, Giuseppe Felice Mangiatordi, Pietro Delre, Petra Heffeter, Eddy Sotelo, Carmen Abate	5
11	Human serum albumin as a copper source for anticancer thiosemicarbazones 2023 ·Metallomics ·(unknown), (unknown), (unknown), Bertrand Vileno, Sonja Hager, Bernhard K. Keppler, Petra Heffeter, Gunda Koellensperger, Peter Faller, Christian R. Kowol	5
12	CD47-targeted cancer immunogene therapy: Secreted SIRPα-Fc fusion protein eradicates tumors by macrophage and NK cell activation 2021 ·Molecular Therapy — Oncolytics ·(unknown), (unknown), Hemma Schueffl, (unknown), (unknown), (unknown), (unknown), Julia Maier, Martina Anton, (unknown), (unknown), Petra Heffeter, Haider Sami, Manfred Ogris	13
13	Interfering with Metabolic Profile of Triple‐Negative Breast Cancers Using Rationally Designed Metformin Prodrugs 2021 ·Angewandte Chemie International Edition ·Maria V. Babak, (unknown), Peter Rapta, (unknown), (unknown), (unknown), (unknown), (unknown), Petra Heffeter, Samuel M. Meier, (unknown), (unknown), Angela Casini, Irina V. Balyasnikova, Wee Han Ang	57
14	Metal- and metalloid-based compounds to target and reverse cancer multidrug resistance 2021 ·Drug Resistance Updates ·Andreia Valente, Ana Podolski-Renić, (unknown), Nenad R. Filipović, Óscar López, Iztok Turel, Petra Heffeter	75
15	The First Anticancer Tris(pyrazolyl)borate Molybdenum(IV) Complexes: Tested in Vitro and in Vivo—A Comparison of O,O‐, S,O‐, and N,N‐Chelate Effects 2019 ·Chemistry - A European Journal ·(unknown), Klaudia Cseh, Alexander Roller, Michaela Hejl, Petra Heffeter, Walter Berger, Michael A. Jakupec, Wolfgang Kandioller, (unknown), Bernhard K. Keppler	10
16	The Natural Fungal Metabolite Beauvericin Exerts Anticancer Activity In Vivo: A Pre-Clinical Pilot Study 2017 ·Toxins ·(unknown), Yelko Rodríguez-Carrasco, Bernhard Englinger, Gerald Timelthaler, Sushilla van Schoonhoven, Michael Sulyok, Simon Boecker, Roderich D. Süßmuth, Petra Heffeter, Rosa Lemmens‐Gruber, Rita Dornetshuber-Fleiss, Walter Berger	28
17	Trabectedin Is Active against Malignant Pleural Mesothelioma Cell and Xenograft Models and Synergizes with Chemotherapy and Bcl-2 Inhibition In Vitro 2016 ·Molecular Cancer Therapeutics ·Mir Alireza Hoda, Christine Pirker, (unknown), Karin Schelch, Petra Heffeter, Kushtrim Kryeziu, Sushilla van Schoonhoven, Thomas Klikovits, Viktória László, Anita Rózsás, (unknown), Walter Klepetko, Balázs Döme, Michael Grusch, Balázs Hegedűs, Walter Berger	17
18	Calpain-Mediated Integrin Deregulation as a Novel Mode of Action for the Anticancer Gallium Compound KP46 2014 ·Molecular Cancer Therapeutics ·Ute Jungwirth, Johannes Gojo, (unknown), Gernot Walko, Martin Holcmann, (unknown), Karin Nowikovsky, (unknown), Sushilla van Schoonhoven, Christian R. Kowol, Rosa Lemmens‐Gruber, Petra Heffeter, Bernhard K. Keppler, Walter Berger	19
19	Synergistic Anticancer Activity of Arsenic Trioxide with Erlotinib Is Based on Inhibition of EGFR-Mediated DNA Double-Strand Break Repair 2013 ·Molecular Cancer Therapeutics ·Kushtrim Kryeziu, Ute Jungwirth, Mir Alireza Hoda, Franziska Ferk, Siegfried Knasmüller, (unknown), Christian R. Kowol, Walter Berger, Petra Heffeter	44
20	The ruthenium compound KP1339 potentiates the anticancer activity of sorafenib in vitro and in vivo 2013 ·European Journal of Cancer ·Petra Heffeter, (unknown), Kushtrim Kryeziu, Diana Groza, Gunda Koellensperger, Wilfried Körner, Ute Jungwirth, Thomas Mohr, Bernhard K. Keppler, Walter Berger	73

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact